These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 627000)

  • 1. Metastatic cloacogenic carcinoma of the anus: sequential responses to adriamycin and cis-dichlorodiammineplatinum(II).
    Fisher WB; Herbst KD; Sims JE; Critchfield CF
    Cancer Treat Rep; 1978 Jan; 62(1):91-7. PubMed ID: 627000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Two cases of cloacogenic carcinoma of the anal canal: chemotherapeutic effect of cis-dichlorodiammine-platinum].
    Ohzato H; Satomi T; Sakita I; Ishida H; Hoshi O; Kawasaki T; Sakaguchi A
    Nihon Geka Gakkai Zasshi; 1988 Aug; 89(8):1291-5. PubMed ID: 3185497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical trial of combined therapy with adriamycin and cis-dichlorodiammineplatinum(II).
    Mills RC; Maurer LH; Forcier RJ; Grace WR; Burke GP; Karp DD; Smith RC; Mcintyre OR; Bean C
    Cancer Treat Rep; 1977; 61(3):477-9. PubMed ID: 872146
    [No Abstract]   [Full Text] [Related]  

  • 4. Adriamycin-cyclophosphamide and adriamycin-cis-dichloro-diammineplatinum(II) combination chemotherapy in patients with advanced cancer.
    Higby DJ; Wilbur D; Wallace HJ; Henderson ES; Weiss R
    Cancer Treat Rep; 1977 Aug; 61(5):869-73. PubMed ID: 329980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Chemotherapy of metastatic urothelial carcinoma].
    Kihara K; Sakuramoto T; Washizuka M; Kawai T; Ogawa M
    Gan To Kagaku Ryoho; 1982 Nov; 9(11):2046-7. PubMed ID: 6892194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Case report of long term survivor of metastatic cloacogenic carcinoma of the anal canal with chemotherapy.
    Fayaz S; Vasishta S; Motawy M
    Gulf J Oncolog; 2007 Jul; (2):65-8. PubMed ID: 20084726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase II trial adriamycin and cis-dichlorodiammineplatinum(II) in squamous cell, ovarian, and testicular carcinomas.
    Bonomi PD; Slayton RE; Wolter J
    Cancer Treat Rep; 1978 Aug; 62(8):1211-3. PubMed ID: 356979
    [No Abstract]   [Full Text] [Related]  

  • 8. cis-Dichlorodiammineplatinum(II) in childhood cancer.
    Freeman AI; Ettinger LJ; Brecher ML
    Cancer Treat Rep; 1979; 63(9-10):1615-20. PubMed ID: 291483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Experience with combination chemotherapy consisting of methotrexate, vinblastine, adriamycin and cisplatin (M-VAC) in advanced urothelial cancer].
    Nishio Y; Shirahase T; Shichiri Y; Habuchi T; Matsuda T; Nishimura K; Hida S; Okada Y; Yoshida O
    Hinyokika Kiyo; 1988 Aug; 34(8):1371-5. PubMed ID: 3195405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. cis-Dichlorodiammineplatinum(II) alone followed by adriamycin plus cyclophosphamide at progression versus cis-dichlorodiammineplatinum(II), adriamycin, and cyclophosphamide in combination for adenocarcinoma of the lung.
    Britell JC; Eagan RT; Ingle JN; Creagen ET; Rubin J; Frytak S
    Cancer Treat Rep; 1978 Aug; 62(8):1207-10. PubMed ID: 688256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. cis-Dichlorodiammineplatinum(II) and adriamycin treatment of advanced ovarian cancer.
    Briscoe KE; Pasmantier MW; Ohnuma T; Kennedy BJ
    Cancer Treat Rep; 1978 Dec; 62(12):2027-30. PubMed ID: 751711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advanced ovarian carcinoma: a pilot study of cis-dichlorodiammineplatinum(II) in combination with adriamycin and cyclophosphamide in previously untreated patients and as a single agent in previously treated patients.
    Williams CJ; Stevenson KE; Buchanan RB; Whitehouse JM
    Cancer Treat Rep; 1979; 63(11-12):1745-53. PubMed ID: 393378
    [No Abstract]   [Full Text] [Related]  

  • 13. [Chemotherapy in advanced transitional cell carcinoma of the urinary tract. Phase II trial of a combination of doxorubicin and cisplatin].
    Ribrag V; Ghnassia M; Théodore C; Ghosn M; Piot G; Beurton D; Cukier J; Droz JP
    J Urol (Paris); 1990; 96(7):373-4. PubMed ID: 2290037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Aggressive preoperative chemotherapy in infiltrating bladder carcinoma with a combination of cisplatin, cyclophosphamide and adriamycin. Preliminary report].
    Martínez-Piñeiro JA; de la Peña JJ; Hidalgo L; Cisneros J; Jiménez de León J; Machuca J
    Arch Esp Urol; 1986; 39(1):33-46. PubMed ID: 3707210
    [No Abstract]   [Full Text] [Related]  

  • 15. [Complete remission of bladder cancer with multiple pulmonary metastases obtained by combined chemotherapy with cis-platinum, adriamycin and cyclophosphamide].
    Takigawa H; Odachi M; Kagawa S; Kurokawa K
    Gan To Kagaku Ryoho; 1985 Sep; 12(9):1877-9. PubMed ID: 4041165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemotherapy of metastatic bladder cancer.
    Yagoda A
    Cancer; 1980 Apr; 45(7 Suppl):1879-88. PubMed ID: 7189443
    [No Abstract]   [Full Text] [Related]  

  • 17. [Cutaneous metastasis of a cloacogenic tumor].
    Peppe H; Bianchi C; Bianchi O; Stringa S
    Med Cutan Ibero Lat Am; 1987; 15(4):293-7. PubMed ID: 3320623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination chemotherapy for ovarian carcinoma with cyclophosphamide, adriamycin, and cis-dichlorodiammineplatinum(II) after failure of initial chemotherapy.
    Bruckner HW; Ratner LH; Cohen CJ; Wallach R; Kabakow B; Greenspan EM; Holland JF
    Cancer Treat Rep; 1978 Jul; 62(7):1021-3. PubMed ID: 688244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Radiotherapy of carcinomas of the anal canal. Tenon Hospital experience].
    Touboul E; Moureau-Zabotto L; Lerouge D; Pène F; Deniaud-Alexandre E; Tiret E; Sezeur A; Houry S; Gallot D; Parc R; Schlienger M; Laugier A
    Cancer Radiother; 2003 Nov; 7 Suppl 1():91s-99s. PubMed ID: 15124550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preliminary results of M-VAC chemotherapy combined with mild hyperthermia, a new therapeutic strategy for advanced or metastatic transitional cell carcinoma of the urothelium.
    Yamada Y; Itoh Y; Aoki S; Nakamura K; Taki T; Naruse K; Tobiume M; Zennami K; Katsuda R; Kato Y; Watanabe M; Nishikawa G; Minami M; Nakahira M; Ukai S; Sawada M; Kitamura A; Honda N
    Cancer Chemother Pharmacol; 2009 Nov; 64(6):1079-83. PubMed ID: 19277660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.